Cargando…

Integrated Immunohistochemical Study on Small-Cell Carcinoma of the Lung Focusing on Transcription and Co-Transcription Factors

Small-cell lung cancer (SCLC) is an aggressive malignant cancer that is classified into four subtypes based on the expression of the following key transcription and co-transcription factors: ASCL1, NEUROD1, YAP1, and POU2F3. The protein expression levels of these key molecules may be important for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Younosuke, Okamoto, Isamu, Kameyama, Hiroki, Kudoh, Shinji, Saito, Haruki, Sanada, Mune, Kudo, Noritaka, Wakimoto, Joeji, Fujino, Kosuke, Ikematsu, Yuki, Tanaka, Kentaro, Nishikawa, Ayako, Sakaguchi, Ryo, Ito, Takaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697657/
https://www.ncbi.nlm.nih.gov/pubmed/33202998
http://dx.doi.org/10.3390/diagnostics10110949
_version_ 1783615647901548544
author Sato, Younosuke
Okamoto, Isamu
Kameyama, Hiroki
Kudoh, Shinji
Saito, Haruki
Sanada, Mune
Kudo, Noritaka
Wakimoto, Joeji
Fujino, Kosuke
Ikematsu, Yuki
Tanaka, Kentaro
Nishikawa, Ayako
Sakaguchi, Ryo
Ito, Takaaki
author_facet Sato, Younosuke
Okamoto, Isamu
Kameyama, Hiroki
Kudoh, Shinji
Saito, Haruki
Sanada, Mune
Kudo, Noritaka
Wakimoto, Joeji
Fujino, Kosuke
Ikematsu, Yuki
Tanaka, Kentaro
Nishikawa, Ayako
Sakaguchi, Ryo
Ito, Takaaki
author_sort Sato, Younosuke
collection PubMed
description Small-cell lung cancer (SCLC) is an aggressive malignant cancer that is classified into four subtypes based on the expression of the following key transcription and co-transcription factors: ASCL1, NEUROD1, YAP1, and POU2F3. The protein expression levels of these key molecules may be important for the formation of SCLC characteristics in a molecular subtype-specific manner. We expect that immunohistochemistry (IHC) of these molecules may facilitate the diagnosis of the specific SCLC molecular subtype and aid in the appropriate selection of individualized treatments. We attempted IHC of the four key factors and 26 candidate SCLC target molecules selected from the gene expression omnibus datasets of 47 SCLC samples, which were grouped based on positive or negative results for the four key molecules. We examined differences in the expression levels of the candidate targets and key molecules. ASCL1 showed the highest positive rate in SCLC samples, and significant differences were observed in the expression levels of some target molecules between the ASCL1-positive and ASCL1-negative groups. Furthermore, the four key molecules were coordinately and simultaneously expressed in SCLC cells. An IHC study of ASCL1-positive samples showed many candidate SCLC target molecules, and IHC could become an essential method for determining SCLC molecular subtypes.
format Online
Article
Text
id pubmed-7697657
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76976572020-11-29 Integrated Immunohistochemical Study on Small-Cell Carcinoma of the Lung Focusing on Transcription and Co-Transcription Factors Sato, Younosuke Okamoto, Isamu Kameyama, Hiroki Kudoh, Shinji Saito, Haruki Sanada, Mune Kudo, Noritaka Wakimoto, Joeji Fujino, Kosuke Ikematsu, Yuki Tanaka, Kentaro Nishikawa, Ayako Sakaguchi, Ryo Ito, Takaaki Diagnostics (Basel) Article Small-cell lung cancer (SCLC) is an aggressive malignant cancer that is classified into four subtypes based on the expression of the following key transcription and co-transcription factors: ASCL1, NEUROD1, YAP1, and POU2F3. The protein expression levels of these key molecules may be important for the formation of SCLC characteristics in a molecular subtype-specific manner. We expect that immunohistochemistry (IHC) of these molecules may facilitate the diagnosis of the specific SCLC molecular subtype and aid in the appropriate selection of individualized treatments. We attempted IHC of the four key factors and 26 candidate SCLC target molecules selected from the gene expression omnibus datasets of 47 SCLC samples, which were grouped based on positive or negative results for the four key molecules. We examined differences in the expression levels of the candidate targets and key molecules. ASCL1 showed the highest positive rate in SCLC samples, and significant differences were observed in the expression levels of some target molecules between the ASCL1-positive and ASCL1-negative groups. Furthermore, the four key molecules were coordinately and simultaneously expressed in SCLC cells. An IHC study of ASCL1-positive samples showed many candidate SCLC target molecules, and IHC could become an essential method for determining SCLC molecular subtypes. MDPI 2020-11-13 /pmc/articles/PMC7697657/ /pubmed/33202998 http://dx.doi.org/10.3390/diagnostics10110949 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sato, Younosuke
Okamoto, Isamu
Kameyama, Hiroki
Kudoh, Shinji
Saito, Haruki
Sanada, Mune
Kudo, Noritaka
Wakimoto, Joeji
Fujino, Kosuke
Ikematsu, Yuki
Tanaka, Kentaro
Nishikawa, Ayako
Sakaguchi, Ryo
Ito, Takaaki
Integrated Immunohistochemical Study on Small-Cell Carcinoma of the Lung Focusing on Transcription and Co-Transcription Factors
title Integrated Immunohistochemical Study on Small-Cell Carcinoma of the Lung Focusing on Transcription and Co-Transcription Factors
title_full Integrated Immunohistochemical Study on Small-Cell Carcinoma of the Lung Focusing on Transcription and Co-Transcription Factors
title_fullStr Integrated Immunohistochemical Study on Small-Cell Carcinoma of the Lung Focusing on Transcription and Co-Transcription Factors
title_full_unstemmed Integrated Immunohistochemical Study on Small-Cell Carcinoma of the Lung Focusing on Transcription and Co-Transcription Factors
title_short Integrated Immunohistochemical Study on Small-Cell Carcinoma of the Lung Focusing on Transcription and Co-Transcription Factors
title_sort integrated immunohistochemical study on small-cell carcinoma of the lung focusing on transcription and co-transcription factors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697657/
https://www.ncbi.nlm.nih.gov/pubmed/33202998
http://dx.doi.org/10.3390/diagnostics10110949
work_keys_str_mv AT satoyounosuke integratedimmunohistochemicalstudyonsmallcellcarcinomaofthelungfocusingontranscriptionandcotranscriptionfactors
AT okamotoisamu integratedimmunohistochemicalstudyonsmallcellcarcinomaofthelungfocusingontranscriptionandcotranscriptionfactors
AT kameyamahiroki integratedimmunohistochemicalstudyonsmallcellcarcinomaofthelungfocusingontranscriptionandcotranscriptionfactors
AT kudohshinji integratedimmunohistochemicalstudyonsmallcellcarcinomaofthelungfocusingontranscriptionandcotranscriptionfactors
AT saitoharuki integratedimmunohistochemicalstudyonsmallcellcarcinomaofthelungfocusingontranscriptionandcotranscriptionfactors
AT sanadamune integratedimmunohistochemicalstudyonsmallcellcarcinomaofthelungfocusingontranscriptionandcotranscriptionfactors
AT kudonoritaka integratedimmunohistochemicalstudyonsmallcellcarcinomaofthelungfocusingontranscriptionandcotranscriptionfactors
AT wakimotojoeji integratedimmunohistochemicalstudyonsmallcellcarcinomaofthelungfocusingontranscriptionandcotranscriptionfactors
AT fujinokosuke integratedimmunohistochemicalstudyonsmallcellcarcinomaofthelungfocusingontranscriptionandcotranscriptionfactors
AT ikematsuyuki integratedimmunohistochemicalstudyonsmallcellcarcinomaofthelungfocusingontranscriptionandcotranscriptionfactors
AT tanakakentaro integratedimmunohistochemicalstudyonsmallcellcarcinomaofthelungfocusingontranscriptionandcotranscriptionfactors
AT nishikawaayako integratedimmunohistochemicalstudyonsmallcellcarcinomaofthelungfocusingontranscriptionandcotranscriptionfactors
AT sakaguchiryo integratedimmunohistochemicalstudyonsmallcellcarcinomaofthelungfocusingontranscriptionandcotranscriptionfactors
AT itotakaaki integratedimmunohistochemicalstudyonsmallcellcarcinomaofthelungfocusingontranscriptionandcotranscriptionfactors